Is the "unresected" glioblastoma population a real specific entity?
作者信息
Dhermain Frederic
机构信息
Institut Gustave Roussy, Radiation Therapy Department, Villejuif, France.
出版信息
Neurooncol Pract. 2023 Aug 22;10(6):502-503. doi: 10.1093/nop/npad051. eCollection 2023 Dec.
Abstract
摘要
相似文献
1
Is the "unresected" glioblastoma population a real specific entity?
Neurooncol Pract. 2023 Aug 22;10(6):502-503. doi: 10.1093/nop/npad051. eCollection 2023 Dec.
2
Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma.
J Neurosurg. 2022 Jul 29;138(3):610-620. doi: 10.3171/2022.5.JNS212761. Print 2023 Mar 1.
3
Cost-effectiveness analysis of the addition of bevacizumab to temozolomide therapy for the treatment of unresected glioblastoma.
Oncol Lett. 2020 Jan;19(1):424-430. doi: 10.3892/ol.2019.11099. Epub 2019 Nov 14.
4
Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.
Transl Oncol. 2024 Apr;42:101897. doi: 10.1016/j.tranon.2024.101897. Epub 2024 Feb 9.
5
Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.
Clin Transl Oncol. 2018 Dec;20(12):1529-1537. doi: 10.1007/s12094-018-1883-7. Epub 2018 May 8.
6
Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.
7
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.
J Neurooncol. 2016 May;127(3):569-79. doi: 10.1007/s11060-016-2065-5. Epub 2016 Feb 3.
8
Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003-2014: a large international population-based study.
Int J Cancer. 2018 Dec 15;143(12):3227-3239. doi: 10.1002/ijc.31628. Epub 2018 Oct 3.
9
Preservation of Memory Despite Unresected Contralateral Hippocampal Volume Loss After Resection of Hippocampal Sclerosis in Seizure-Free Patients.
World Neurosurg. 2019 Dec;132:e759-e765. doi: 10.1016/j.wneu.2019.08.021. Epub 2019 Aug 12.
10
Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma.
World J Surg Oncol. 2021 Oct 18;19(1):303. doi: 10.1186/s12957-021-02412-1.
引用本文的文献
1
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study.
Acta Neurochir (Wien). 2024 Oct 5;166(1):394. doi: 10.1007/s00701-024-06300-x.
本文引用的文献
1
Radio-chemotherapy feasibility for biopsy-only unresectable wild-type glioblastomas (BO-GBM).
Neurooncol Pract. 2023 May 30;10(6):536-543. doi: 10.1093/nop/npad028. eCollection 2023 Dec.
2
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.
Neuro Oncol. 2022 Oct 5;24(Suppl 5):v1-v95. doi: 10.1093/neuonc/noac202.
3
Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma.
J Neurosurg. 2022 Jul 29;138(3):610-620. doi: 10.3171/2022.5.JNS212761. Print 2023 Mar 1.
4
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
J Neurooncol. 2019 Oct;145(1):97-105. doi: 10.1007/s11060-019-03271-3. Epub 2019 Aug 27.
5
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
JAMA. 2017 Dec 19;318(23):2306-2316. doi: 10.1001/jama.2017.18718.
6
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
N Engl J Med. 2017 Mar 16;376(11):1027-1037. doi: 10.1056/NEJMoa1611977.
7
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.
Ann Oncol. 2014 Jul;25(7):1442-1447. doi: 10.1093/annonc/mdu148. Epub 2014 Apr 9.
8
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
N Engl J Med. 2014 Feb 20;370(8):709-22. doi: 10.1056/NEJMoa1308345.
9
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330.
10
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.
J Clin Oncol. 2002 Mar 1;20(5):1375-82. doi: 10.1200/JCO.2002.20.5.1375.
Zotero 插件